NFKB1 and cancer: In addition to inhibiting the Na+/K+-ATPase ion pumping function, cardenolide glycosides affect the activity of transcription factors and the inhibition of the NF-κB pathway has emerged as a hallmark of cardenolide glycoside pharmacodynamics in cancer cells (Diederich et al., 2017; Schneider et al., 2017).